Research Project · Health
Drug Development RFP
Alzheimer's Drug Discovery Foundationwww.alzdiscovery.org (opens in a new tab)Catalog updated
- Amount
- $5,000,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Alzheimer's Drug Discovery Foundation (ADDF) offers up to $5,000,000 in funding through its Drug Development RFP to support IND-enabling studies and early-phase clinical trials for innovative pharmacological interventions and devices targeting Alzheimer's disease and related dementias. Focus areas include combination therapies, disease-modifying agents, and novel drug mechanisms related to aging, excluding anti-amyloid approaches and cholinesterase inhibitors.
Applicants must provide compelling evidence for the proposed mechanism, preliminary data, and a strong investigative team. Eligible applicants include researchers and clinicians worldwide from academic medical centers, universities, nonprofits, and biotechnology companies, with industry partnerships strongly encouraged. Clinical trials must register on ClinicalTrials.gov.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.
Ask for a demo of this program The form opens already filled in.